Articles > Popular publications > PR Newswire press releases > October-December 2009 > Monday, November 9

Article: Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide.

Article from:
PR Newswire
Article date:
November 9, 2009
Copyright

In clinical studies, INTUNIV, a nonscheduled treatment for ADHD, demonstrated significant improvement in reducing ADHD symptoms which can be disruptive at home and at school

PHILADELPHIA, Nov. 9 /PRNewswire-FirstCall/ -- Shire plc , the global specialty biopharmaceutical company, today announced the availability of INTUNIV(TM) (guanfacine) Extended Release Tablets in pharmacies across the United States for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents ages 6 to 17. INTUNIV, a once-daily formulation of guanfacine, is the first and only nonscheduled alpha-2A receptor agonist approved for the treatment of ADHD. In ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Shire's INTUNIV Guanfacine extended release in children ...
NewsRx Health;  June 7, 2009 ;     700+ words ... ... for the clinical efficacy of INTUNIV for treating ADHD in this patient population ... approved for the treatment of ADHD. INTUNIV Demonstrated Significant Efficacy ... demonstrated significant reduction in ADHD symptoms. INTUNIV is not a controlled substance ...

Article: New Data Show Once-Daily INTUNIV(TM) (guanfacine) Extended ...
PR Newswire;  October 29, 2009 ;     700+ words ... ... treating a range of ADHD symptoms." INTUNIV, a once-daily ... nine-week period. INTUNIV demonstrated significant ADHD symptom improvement ... inattentive ADHD symptoms. ADHD-RS-IV mean change from baseline for INTUNIV versus placebo was ...

Article: New Data Show Once-Daily INTUNIV™ (guanfacine) ...
Biotech Week;  November 11, 2009 ;     700+ words ... ... for treating a range of ADHD symptoms." INTUNIV, a once-daily formulation ... nine-week period. INTUNIV demonstrated significant ADHD symptom improvement in ... available at http://www.intuniv.com/. Keywords: ADHD, Adrenergic alpha ...

Article: INTUNIV demonstrated symptom reduction on oppositional ...
NewsRx Health & Science;  November 22, 2009 ;     700+ words ... ... treating a range of ADHD symptoms." INTUNIV, a once-daily ... nine-week period. INTUNIV demonstrated significant ADHD symptom improvement ... inattentive ADHD symptoms. ADHD-RS-IV mean change from baseline for INTUNIV versus placebo was ...

Article: New Data Show Once-Daily INTUNIV guanfacine Extended ...
Pediatrics Week;  November 14, 2009 ;     700+ words ... ... treating a range of ADHD symptoms." INTUNIV, a once-daily ... nine-week period. INTUNIV demonstrated significant ADHD symptom improvement ... http://www.intuniv.com/. Keywords ... Psychiatric, Psychiatry, ADHD, Adrenergic alpha ...

Article: Shire Announces Study Results of the Effects of ...
PR Newswire;  May 18, 2009 ;     700+ words ... ... for the clinical efficacy of INTUNIV for treating ADHD in this patient population ... approved for the treatment of ADHD. INTUNIV Demonstrated Significant Efficacy ... demonstrated significant reduction in ADHD symptoms. INTUNIV is not a controlled substance ...

Article: Shire's Intuniv improves ADHD upto 24hrs post ...
Pharma Marketletter;  May 19, 2008 ;     700+ words ... ... studies was change in the ADHD Rating Scale total score ... patient groups treated with Intuniv showed significantly greater improvement in ADHD-RS-IV total score ... administration of the dose of Intuniv, respectively. The data ... significant improvement of ADHD symptoms based on total ...

Article: Shire Announces FDA Approval of Once-Daily INTUNIV ...
Biotech Week;  September 16, 2009 ;     700+ words ... ... behaviors that can be disruptive. INTUNIV expands the Shire ADHD portfolio with a nonscheduled ... http://www.intuniv.com. INTUNIV Demonstrated Significant Reduction in ADHD Symptoms The efficacy of INTUNIV in the treatment of ADHD was ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives